Key result
Adipocyte dysfunction drives obesity-linked metabolic and cardiovascular complications via dysregulated adipocytokines.
Why the study?
Dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to obesity-linked metabolic and cardiovascular complications.
This review summarizes the functional roles of adipocytokines in metabolic and cardiovascular diseases, highlighting how adipocyte dysfunction contributes to obesity-linked complications.
Answers are grounded in this paper and cite their sources.
Adipocytokine insights may refine obesity-related CVD risk models; leaves open targeted interventions pending prospective validation.
Obesity is closely associated with an increased risk for metabolic and cardiovascular diseases.Adipose tissue produces a number of secretory bioactive substances, also known as adipocytokines or adipokines, which directly affect adjacent or distant organs.Most adipocytokines are pro-inflammatory, thereby promoting the obesity-linked disorders.In contrast, there are a small number of adipocytokines that exhibit anti-inflammatory properties.It is now recognized that dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to the development of obesity-linked complications.In this review, we focus on the functional role of several adipocytokines in metabolic and cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Ouchi et al. (2023) conducted a review in Obesity-linked metabolic and cardiovascular diseases. Adipocytokines was evaluated. Dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to the development of obesity-linked metabolic and cardiovascular complications.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: